Drug Type Monoclonal antibody |
Synonyms REMD 378, REMD378 |
Target |
Mechanism CCR7 inhibitors(C-C motif chemokine receptor 7 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chronic Lymphocytic Leukemia | Preclinical | US | 09 Oct 2023 | |
Non-Hodgkin Lymphoma | Preclinical | US | 09 Oct 2023 |